Literature DB >> 12011375

Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis.

A M Al-Heresh1, J Proctor, S M Jones, J Dixey, B Cox, K Welsh, N McHugh.   

Abstract

OBJECTIVES: To investigate polymorphisms in the genes for tumour necrosis factor alpha (TNFA), interleukin 10 (IL10) and tumour necrosis factor receptor II (TNFRII) in patients with psoriatic arthritis (PsA) and their relationship to the HLA-Cw*0602 allele and to the ages at onset of psoriasis and arthritis and the pattern of joint involvement.
METHODS: One hundred and twenty-four well-characterized patients with PsA were studied. Controls were 101 cadaveric organ donors. All were genotyped for single-nucleotide polymorphisms in TNFA (positions -308, -238, +488), IL10 (-1082, -819, -592) and in the 3'-untranslated region of TNFRII (+1663, +1668, +1690). The HLA-Cw*0602 allele was detected by polymerase chain reaction-based techniques. The frequencies of the respective variants were compared between patients and controls and in relation to the ages at onset of psoriasis and arthritis, to clinical subsets of the disease and to the presence of erosions.
RESULTS: HLA-Cw*0602 was significantly increased in frequency in PsA (40 vs 26%; P<0.05) and was associated with younger age of onset of psoriasis (P<0.05). There was no significant increase in any of the polymorphisms studied within TNFA, IL10 or TNFRII in the total PsA group. Although the frequency of TNFA allele -238A was not increased in the total PsA group or in patients with a younger age of onset of psoriasis, TNFA allele -238A was absent in the spondyloarthritis group and increased in frequency in patients with peripheral polyarthritis. However, these latter findings could be explained by linkage disequilibrium as all TNFA -238A alleles (23/23) in patients with PsA were HLA-Cw*0602-positive (P<0.0001).
CONCLUSIONS: An association between young age of onset of psoriasis and HLA-Cw*0602 is confirmed in patients with PsA. The uncommon TNFA -238A allele is strongly linked to HLA-Cw*0602 and as such is associated with the development of peripheral polyarthritis rather than spondylitis. Further investigation of possible HLA-Cw*0602 linked genes in PsA is warranted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011375     DOI: 10.1093/rheumatology/41.5.525

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  25 in total

1.  A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting.

Authors:  Ari Karason; Johann E Gudjonsson; Ruchi Upmanyu; Arna A Antonsdottir; Valdimar B Hauksson; E Hjaltey Runasdottir; Hjortur H Jonsson; Daniel F Gudbjartsson; Michael L Frigge; Augustine Kong; Kari Stefansson; Helgi Valdimarsson; Jeffrey R Gulcher
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

Review 2.  Genetic factors in psoriatic arthritis.

Authors:  Eleanor Korendowych; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

3.  Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Inflamm Res       Date:  2012-03-18       Impact factor: 4.575

4.  TNFalpha polymorphisms and risk of psoriatic arthritis.

Authors:  P Rahman; F Siannis; C Butt; V Farewell; L Peddle; F Pellett; D Gladman
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

Review 5.  Genetic epidemiology of psoriasis and psoriatic arthritis.

Authors:  P Rahman; J T Elder
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

6.  IL-10 implications in psoriasis.

Authors:  Ahmad A Al-Robaee; Abdullateef A Al-Zolibani; Hani A Al-Shobili; Amira Kazamel; Ahmad Settin
Journal:  Int J Health Sci (Qassim)       Date:  2008-01

Review 7.  Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective.

Authors:  David Kane; Oliver FitzGerald
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

8.  Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients.

Authors:  M Feletar; J E Brockbank; C T Schentag; V Lapp; D D Gladman
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

9.  Human leukocyte antigen (HLA)-Cw0303, HLA-Cw04, and HLA-Cw07 polymorphisms are associated with susceptibility of rheumatoid arthritis in Chinese Han patients from Southern China.

Authors:  Chuankun Yang; Chunling Wang; Yan Shi; Li Li
Journal:  Iran J Basic Med Sci       Date:  2019-06       Impact factor: 2.699

10.  HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis.

Authors:  Pauline Y P C Ho; Anne Barton; Jane Worthington; Wendy Thomson; Alan J Silman; Ian N Bruce
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.